Direkt zum Inhalt
Merck
  • Complexes of α6β4 integrin and vimentin act as signaling hubs to regulate epithelial cell migration.

Complexes of α6β4 integrin and vimentin act as signaling hubs to regulate epithelial cell migration.

Journal of cell science (2018-07-07)
Zachary T Colburn, Jonathan C R Jones
ZUSAMMENFASSUNG

We find that clusters of β4 integrin, organized into distinct puncta, localize along vimentin filaments within lamellipodia at the cell edge of A549 cells, as assessed by interferometric photoactivated localization microscopy. Moreover, puncta and vimentin filaments exhibit a dynamic interplay in live cells, as viewed by structured-illumination microscopy, with β4 integrin puncta that associate with vimentin persisting for longer than those that do not. Interestingly, in A549 cells β4 integrin regulates vimentin cytoskeleton organization. When β4 integrin is knocked down there is a loss of vimentin filaments from lamellipodia. However, in these conditions, vimentin filaments instead concentrate around the nucleus. Although β4 integrin organization is unaffected in vimentin-deficient A549 cells, such cells move in a less-directed fashion and exhibit reduced Rac1 activity, mimicking the phenotype of β4 integrin-deficient A549 cells. Moreover, in vimentin-deficient cells, Rac1 fails to cluster at sites enriched in α6β4 integrin heterodimers. The aberrant motility of both β4 integrin and vimentin-deficient cells is rescued by expression of active Rac1, leading us to propose that complexes of β4 integrin and vimentin act as signaling hubs, regulating cell motility behavior.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Puromycin -dihydrochlorid aus Streptomyces alboniger, powder, BioReagent, suitable for cell culture
Sigma-Aldrich
Nocodazol, ≥99% (TLC), powder
Sigma-Aldrich
Anti-Glyceraldehyd-3-phosphat-dehydrogenase-Antikörper, Klon 6C5, clone 6C5, Chemicon®, from mouse
Sigma-Aldrich
Monoklonales Anti-Vimentin, clone V9, purified immunoglobulin, buffered aqueous solution
Sigma-Aldrich
MISSION® esiRNA, targeting human VIM